Zentalis Pharmaceuticals stock price
NASDAQ:ZNTL · Nasdaq · Healthcare · sector #16Zentalis Pharmaceuticals's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross, Mean reversion. The display ticker is ZNTL.
Zentalis Pharmaceuticals last closed at $2.36 (-1.26%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -0.9×. Its overall grade ranks 677 of 727 stocks in Healthcare.
About this company
Zentalis Pharmaceuticals last closed at $2.36 (-1.26%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 677/727
Valuation grade C+
Related stocks
- AstraZenecaCompetitor
- PfizerCompetitor
- Merck & CoCompetitor
About Zentalis Pharmaceuticals
- What technical signals does Zentalis Pharmaceuticals (ZNTL) have?
- Zentalis Pharmaceuticals current technical signals: RSI rebound, MACD bullish cross, Mean reversion.
- Is Zentalis Pharmaceuticals a cup-and-handle pattern?
- No. Zentalis Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Zentalis Pharmaceuticals?
- Market cap: $170.51M. Trailing 12 months PER: -0.9×. Latest quarter PBR: 1.15×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Zentalis Pharmaceuticals, or open the plan table on the main site.
Ask Q about Zentalis Pharmaceuticals.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.